Results 181 to 190 of about 12,272 (191)

PCSK9 Inhibitors: Novel Therapeutic Strategies for Lowering LDLCholesterol

Mini-Reviews in Medicinal Chemistry, 2019
Zhaopeng Liu
exaly  

PCSK9 inhibitors in clinical practice: Delivering on the promise?

Atherosclerosis, 2018
Merel L Hartgers, Erik Stroes, Katrien Santema   +2 more
exaly  

Piperidine compounds as PCSK9 inhibitors

2018
WU CHENGDE, YAN JIE, XU WENJIE, YU TAO, LI NING, CHEN SHUHUI   +5 more
openaire   +2 more sources

HETEROCYCLIC INHIBITORS OF PCSK9

2022
COGHLAN PHILLIP ALBERT, SUCHOWERSKA ALEXANDRA KALYNA, PALMER JAMES T, BONNAR JAMES ANTHONY, EVISON BENNY   +4 more
openaire   +1 more source

The Oral PCSK9 inhibitor enlicitide for hypercholesterolemia

European Journal of Internal Medicine
Mohammed A. Elbahloul, Aliaa Gamal, Islam Y. Elgendy   +2 more
openaire   +2 more sources

INHIBITORS OF PCSK9

GUSTAFSEN CAMILLA, POLD VILSTRUP JOACHIM, GLERUP PEDERSEN SIMON, GLOSSOP PAUL ALAN, QUATTROPANI ANNA   +4 more
openaire   +1 more source

[First PCSK9 inhibitor].

MMW Fortschritte der Medizin, 2016
openaire   +1 more source

Assay for PCSK9 inhibitors

2012
BEYER BRIAN M, HESSON THOMAS, LE HUNG V, PRONGAY ANDREW J, KALGHATGI KRISHNA, GESELL JENNIFER JOANNE, INGRAM RICHARD N, ZIEBELL MICHAEL R   +7 more
openaire   +1 more source

PCSK9 inhibitors on the way.

Managed care (Langhorne, Pa.), 2015
openaire   +1 more source

DOSING REGIMENS FOR USE WITH PCSK9 INHIBITORS

2019
MARIE BACCARA-DINET, LAURENCE BESSAC, CORINNE HANOTIN, ROBERT C PORDY, WILLIAM J SASIELA, JACQUES REY   +5 more
openaire   +4 more sources